Home Page

DUBLIN, June 24, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the " Cardiac Biomarkers: Technologies and Global Markets" report to their offering.

The global cardiac biomarkers market is expected to grow at a five-year compound annual growth rate (CAGR) of 12.4% from 2015 to 2020, increasing to over $8.8 billion in 2020.

The report includes an analysis of leading and emerging competitors in the current global diagnostics market for CVDs. Profiles of manufacturers of leading products as well as biotechnology companies with products in development are discussed to define their specific product strategies.

The competitive environment is examined, with a special focus on how instrumentation type (clinical chemistry analyzers compared with point-of-care devices) and their respective technologies are influencing the current standard of care. Detailed profiles of current market leaders are discussed, as well as companies with innovative products poised to enter the market during the forecast period.

This report provides:

• An overview of the global market for cardiac biomarkers and related technologies.
• Analyses of global market trends, with data from 2014, 2015, and projections of CAGRs through 2020.
• Classification of cardiac biomarkers by cerebrovascular, congestive, coronary, hypertensive, and peripheral arterial disease.
• Background and clinical values of cardiac biomarkers, including B-type natriuretic peptide (BNP), N-terminal pro-B-type natriuretic peptide (NT-proBNP), C-reactive protein (CRP), choline, creatine kinase MB (CK-MB), D-dimer, glial fibrillary acidic protein (GFAP), heart fatty acid binding protein (H-FABP), ischemia-modified albumin (IMA), myeloperoxidase (MPO), myoglobin, soluble fragment CD40 ligand (sCD40L), and troponin I (cTnI)/troponin T (cTnT).
• Examination of the technology covering diagnostic methods, instrumentation, newly issued patents, and new patent applications.
• Clinical guidelines and government regulations.
• Profiles of major players in the industry.

The report includes an analysis of leading and emerging competitors in the current global diagnostics market for CVDs. Profiles of manufacturers of leading products as well as biotechnology companies with products in development are discussed to define their specific product strategies.

Companies Mentioned:

• Abbott Diagnostics
• Alere Inc.
• Beckman Coulter
• Becton, Dickinson And Co.
• Bg Medicine Inc.
• Biomerieux
• Bio-Rad Laboratories
• Cisbio Bioassays
• Covance
• EKF Diagnostics
• Enzo Biochem Inc.
• Hologic Inc.
• Meso Scale Diagnostics
• Ortho Clinical Diagnostics
• Pacific Biomarkers Inc.
• Perkin Elmer Inc.
• Qiagen Nv
• Radiometer Medical
• Randox Laboratories Ltd.
• Response Biomedical Corp.
• Roche Holding Ag
• Signosis Inc.
• Siemens Healthcare Diagnostics
• Singulex, Inc.
• Thermo Fisher Scientific Inc.
• Wuxi Apptec
• Potential Entrants

Report Structure:

1: Introduction

2: Summary

3: Overview

4: Industry Structure And Competitive Analysis

5: Summary Of Market By Assays

6: Market By Instrument

7: Market By Region

8: Company Profiles

9: Appendix

For more information visit http://www.researchandmarkets.com/research/w3qbvz/_cardiac

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

 

SOURCE Research and Markets